337 filings
Page 4 of 17
8-K
cqnyuzf h8q
7 Dec 21
Pacira BioSciences Reports Preliminary Net Product Sales for EXPAREL® and iovera° of $48.0 Million for November 2021
8:02am
8-K
ng4aal3dzc2agccla6id
19 Nov 21
Pacira BioSciences Completes Acquisition of Flexion Therapeutics and Strengthens Leadership Position in Non-Opioid Pain Management
9:17am
SC TO-T/A
02kms7yexr n4zd50cv
19 Nov 21
Third party tender offer statement (amended)
9:01am
SC TO-T/A
sur6b5eqhhtfsjw0 al
18 Nov 21
Third party tender offer statement (amended)
6:02am
SC TO-T/A
n6sce7j 7d
12 Nov 21
Third party tender offer statement (amended)
6:05am
8-K
a3ipdsslx58l
9 Nov 21
Pacira BioSciences Reports Preliminary Net Product Sales of $44.3 Million for October 2021
8:01am
8-K
g4sf7jo
3 Nov 21
Pacira BioSciences Reports Third Quarter 2021 Financial Results
8:04am
SC TO-T/A
1gq65
1 Nov 21
Third party tender offer statement (amended)
4:46pm
SC TO-T
e38waplhjir
22 Oct 21
Third party tender offer statement
6:03am
SC TO-C
0cm0u9nl
12 Oct 21
Information about tender offer
6:08am
8-K
0omxshlmgmq5w is
12 Oct 21
Pacira BioSciences to Acquire Flexion Therapeutics Further Expanding Leadership Position in Non-Opioid Pain Management
6:06am
8-K
5ehbc2rkmvino
15 Sep 21
Pacira BioSciences Reports Preliminary Net Product Sales of $42.3 Million for August 2021
7:31am
8-K
3xhz ldxf0wute4
10 Aug 21
Pacira BioSciences Reports Preliminary Net Product Sales of $42.1 Million for July 2021
8:02am
S-8
64f eiibp
3 Aug 21
Registration of securities for employees
4:31pm
8-K
yv57g82x0okdpf106
3 Aug 21
Pacira BioSciences Reports Record Revenue of $135.6 Million for the Second Quarter of 2021
8:02am
8-K
qn8hs 9y5
13 Jul 21
Pacira BioSciences Reports Record Revenue of $135.6 Million for the Second Quarter of 2021
8:02am
8-K
oimfl9hsyxd9c
17 Jun 21
Departure of Directors or Certain Officers
4:30pm
8-K
1ourrtqv cii
11 Jun 21
Departure of Directors or Certain Officers
4:21pm